Stock Options

6 Months Ended

Feb. 28, 2026

Share-Based Payment Arrangement [Abstract]

Stock Options

NOTE 5 - Stock Options

The Company measures share-based compensation cost on the grant date, based on the fair value of the award, and recognizes the expense on a straight-line basis over the requisite service period for awards expected to vest. The Company estimates the grant date fair value of stock options using a Black-Scholes valuation model. No stock options were granted during the six months ended February 28, 2026 and 2025. A summary of the Company’s stock option activity for the six months ended February 28, 2026 and related information follows:

Schedule of stock option activity
		Number of Shares Subject to Option Grants				Weighted Average Exercise Price ($)				Weighted Average Remaining Contractual Term (years)				Aggregate Intrinsic Value ($)
Outstanding at February 28, 2026			5,206,000				2.37				3.04				37,500
Exercisable at February 28, 2026			5,206,000				2.37				3.04				37,500

The aggregate intrinsic value in the table above represents the total pretax intrinsic value for all “in-the-money” options (i.e. the difference between the Company’s closing stock price on the last trading day of the period covered by this report and the exercise price, multiplied by the number of shares) that would have been received by the option holders had all in-the-money option holders exercised their vested options on February 28, 2026. The intrinsic value of the option changes based upon the fair market value of the Company’s common stock. Since the closing stock price was $0.36 on February 28, 2026 and 1,250,000 outstanding options have an exercise price below $0.36 per share, as of February 28, 2026, there is $37,500 of intrinsic value to the Company’s vested stock options.

The following table sets forth the share-based compensation cost resulting from stock option grants, including those previously granted and vesting over time, that were recorded in the Company’s Statements of Operations for the three and six months ended February 28, 2026 and 2025:

Schedule of share-based compensation
		Three Months Ended February 28,								Six Months Ended February 28,
		2026				2025				2026				2025
Stock compensation expense:
Selling, general and administrative		$	-			$	51,562			$	-			$	103,125

The following table summarizes information about stock options outstanding and exercisable at February 28, 2026:

	Schedule of Stock Options Outstanding
					Stock Options Outstanding												Stock Options Exercisable
	Range of Exercise Prices				Number of Shares Subject to Outstanding Options				Weighted Average Contractual Life (years)				Weighted Average Exercise Price ($)				Number of Shares Subject To Options Exercise				Weighted Average Remaining Contractual Life (Years)				Weighted Average Exercise Price ($)
	0.33				1,250,000				3.11				0.33				1,250,000				3.11				0.33
	2.32				153,000				3.62				2.32				153,000				3.62				2.32
	2.60				2,500,000				2.94				2.60				2,500,000				2.94				2.60
	3.42				50,000				0.64				3.42				50,000				0.64				3.42
	3.54				1,033,000				2.94				3.54				1,033,000				2.94				3.54
	4.87				110,000				2.72				4.87				110,000				2.72				4.87
	6.21				110,000				5.67				6.21				110,000				5.67				6.21
	Total				5,206,000				3.04				2.37				5,206,000				3.04				2.37